Calnexin antibody (AA 1-300)
Quick Overview for Calnexin antibody (AA 1-300) (ABIN7869119)
Target
See all Calnexin (CANX) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 1-300
-
Purpose
- Calnexin Antibody
-
Purification
- Protein G affinity chromatography
-
Immunogen
- A portion of amino acids 1-300 from the human protein was used as the immunogen for the Calnexin antibody.
-
Isotype
- IgG1, kappa
-
-
-
-
Application Notes
- Titering of the Calnexin antibody may be required for optimal performance.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the Calnexin antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- Calnexin (CANX)
-
Alternative Name
- Calnexin
-
Background
- It recognizes a protein of 90 kDa, which is identified as Calnexin. Secretory and transmembrane proteins are synthesized on polysomes and translocate into the endoplasmic reticulum (ER) where they are often modified by the formation of disulfide bonds, amino-linked glycosylation and folding. To help proteins fold properly, the ER contains a pool of molecular chaperones including calnexin. It is a calcium-binding, endoplasmic reticulum (ER)-associated protein that interacts transiently with newly synthesized N-linked glycoproteins, facilitating protein folding and assembly. It may also play a central role in the quality control of protein folding by retaining incorrectly folded protein subunits within the ER for degradation.
-
UniProt
- P27824
-
Pathways
- MAPK Signaling, Thyroid Hormone Synthesis
Target
-